Novel strategy for treatment of inner ears using a biodegradable gel.
about
Improved Auditory Nerve Survival with Nanoengineered Supraparticles for Neurotrophin Delivery into the Deafened CochleaSolid lipid nanoparticles loaded with edaravone for inner ear protection after noise exposure.Sustained release of triamcinolone acetonide from an intratympanically applied hydrogel designed for the delivery of high glucocorticoid doses.Mechanisms of sensorineural cell damage, death and survival in the cochlea.Effects of brain-derived neurotrophic factor (BDNF) and electrical stimulation on survival and function of cochlear spiral ganglion neurons in deafened, developing cats.The use of a dual PEDOT and RGD-functionalized alginate hydrogel coating to provide sustained drug delivery and improved cochlear implant functionBrain-derived neurotrophic factor modulates auditory function in the hearing cochlea.Intracochlear drug delivery systems.Distribution of dexamethasone and preservation of inner ear function following intratympanic delivery of a gel-based formulation.Kinetics of reciprocating drug delivery to the inner earBrain-derived neurotrophic factor promotes cochlear spiral ganglion cell survival and function in deafened, developing cats.Localized cell and drug delivery for auditory prostheses.Drug delivery for treatment of inner ear disease: current state of knowledgeTopical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial.Principles of local drug delivery to the inner ear.Inner ear drug delivery for auditory applications.Neurotrophic factors and neural prostheses: potential clinical applications based upon findings in the auditory system.Dexamethasone released from cochlear implant coatings combined with a protein repellent hydrogel layer inhibits fibroblast proliferation.A novel chitosan-hydrogel-based nanoparticle delivery system for local inner ear application.Targeted delivery of Tet1 peptide functionalized polymersomes to the rat cochlear nerveEnhanced bioavailability of nerve growth factor with phytantriol lipid-based crystalline nanoparticles in cochleaOzone Prevents Cochlear Damage From Ischemia-Reperfusion Injury in Guinea Pigs.Drug delivery systems for the treatment of sensorineural hearing loss.Neurotrophins and cochlear implants: a solution to sensorineural deafness?Nanomedicine strategies for drug delivery to the ear.Dexamethasone levels and base-to-apex concentration gradients in the scala tympani perilymph after intracochlear delivery in the guinea pig.A microfluidic reciprocating intracochlear drug delivery system with reservoir and active dose control.Simulation of application strategies for local drug delivery to the inner ear.Local application of hepatocyte growth factor using gelatin hydrogels attenuates noise-induced hearing loss in guinea pigs.Inner ear drug delivery system from the clinical point of view.Principles of inner ear sustained release following intratympanic administration.Biomimetic Artificial Basilar Membranes for Next-Generation Cochlear Implants.Transplantation of neurons derived from human iPS cells cultured on collagen matrix into guinea-pig cochleae.Microfabricated infuse-withdraw micropump component for an integrated inner-ear drug-delivery platform.Long-term delivery of brain-derived neurotrophic factor (BDNF) from nanoporous silica nanoparticles improves the survival of spiral ganglion neurons in vitro.Novel drug delivery systems for inner ear protection and regeneration after hearing loss
P2860
Q28553035-3965D125-0050-43C7-A540-3956C7740D7CQ30384387-0C6D9862-C207-4FBB-BE3D-1928EEEFC3E3Q30392675-46E7BDA5-590D-44E5-8196-D380EBEA1FF6Q30412447-B1EF5AB6-87B7-4A05-9ED3-7CC8A01E175BQ30440839-2E68E3CE-C541-42C6-9B02-83685CAC6682Q30457690-51712521-53C1-4CCE-9ED1-3B3A01F252A7Q30458638-9D137C7B-CE9B-4413-AFE5-6550C5473A1BQ30464082-DEACC54E-2AE1-43A8-BE52-BAC1099CD3D3Q30466045-5B4A5EB7-9EE2-4DA3-9352-C469B648E8CCQ30466728-FC8B0B02-317B-446B-B2E3-C10B5184CD31Q30467124-792968B3-EC78-4953-8813-1A173B0E56EAQ30475885-5FA93270-CA48-4F0D-BBDA-42F4CFD5AE04Q30476020-45C573B0-A7EB-4C3E-BEB3-547469919EE0Q30478217-C129DD6E-870E-4B9B-A224-107CB9625D97Q30478838-D7275AC6-4EAE-4703-A1F6-B0C929373BB2Q30484636-2A4F6330-3752-49C0-85C7-EEB9057FEA38Q30498580-D4B35889-8452-4DDE-8718-F43264B04983Q34637454-DB478B9B-0849-46F6-ADFA-05F0D42A6C36Q35193795-DA3CA91A-BC0F-47FB-9829-B8CAF542E1A4Q35797524-5B032071-E9E7-4F4C-A5B3-25A757C5A5D8Q36265255-043A1788-B577-4788-9F09-A179ED26DF45Q36297817-EC47E968-6CF8-4498-96DA-C3BAE1D20703Q36799313-A982CF5A-E91A-443F-839D-83C6A8689DA5Q38034287-DB148A68-0F58-4FC5-B996-F068247D166EQ38120319-65AC5377-5177-4431-8E34-9826779A38DFQ41810387-5B6194D5-BE9A-47B8-B2D8-3E923EF5667EQ41891299-9B2A9DE5-6E41-4EB1-AF30-431000A8A295Q41938982-9F4BA5F1-1E92-4564-87C8-A9F1F2719325Q42449360-88EBACD7-0F5D-47F3-AADF-86861A62C463Q42873726-AC9DFE91-EE1C-4F72-AD4A-4A9DF285D882Q46652572-3D99E01D-1358-4A72-913B-92BCE7F9B828Q47690116-36CB8896-D2A1-4D84-B8F6-038593F939C3Q50352178-F2867087-4D48-4908-9108-8C90F066EB01Q53312095-36F16AF0-A0D7-4F8D-91B5-46DB1CAD0584Q55294611-64C81646-3C5D-4471-826B-5F397DA504B0Q58767632-8D50EEB3-FC52-46EE-B462-A3D4131D012F
P2860
Novel strategy for treatment of inner ears using a biodegradable gel.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Novel strategy for treatment of inner ears using a biodegradable gel.
@en
Novel strategy for treatment of inner ears using a biodegradable gel.
@nl
type
label
Novel strategy for treatment of inner ears using a biodegradable gel.
@en
Novel strategy for treatment of inner ears using a biodegradable gel.
@nl
prefLabel
Novel strategy for treatment of inner ears using a biodegradable gel.
@en
Novel strategy for treatment of inner ears using a biodegradable gel.
@nl
P2093
P1433
P1476
Novel strategy for treatment of inner ears using a biodegradable gel.
@en
P2093
Fukuichiro Iguchi
Juichi Ito
Tae-Soo Kim
Takayuki Nakagawa
Tetsuya Tamura
Tomoko Kita
Tsuyoshi Endo
Yasuhiko Tabata
P304
P356
10.1097/01.MLG.0000183020.32435.59
P407
P577
2005-11-01T00:00:00Z